全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

How Silencing of Dissent in Science Impacts Woman. The Gardasil® Story

DOI: 10.4236/asm.2017.74015, PP. 179-204

Keywords: Vaccine Opposition, Human Papillomavirus, Vaccines, Adverse Reactions, Gardasil®, Cervarix®

Full-Text   Cite this paper   Add to My Lib

Abstract:

The issues of safety and efficacy of certain vaccines remains extremely contentious. The venues for this debate have included periodicals, documentary films, and an ever-increasing number of on-line sites. While debate in science is not only a common occurrence but a fundamental tenet of the scientific community, it only works when divergent opinions can be heard. When those who hold an opposing opinion are denigrated and/or marginalized by those holding the majority opinion such as in the issue of vaccination, where cultural authority for the issue is owned by the profession of medicine, both science and the public lose. What is often forgotten are the benefits derived from the questioning of drug safety that not only extends to the public but to physicians who rely on the truthfulness and accuracy of the information that is being supplied to them by manufactures and government agencies. While most physicians believe they are functioning in their patient’s best interest when making vaccine recommendations, these recommendations by in large have become a matter of rote and are made because most physicians have bought into the “vaccines are safe” mantra. What most physicians don’t realize is they have unknowingly been recruited by big pharma to assist in shutting down the vaccination debate. This suppression of vaccine opposition even among academics, is becoming more commonplace and will lead down a slippery slope that will silence opposition science, and the dangers that come with this. Those who question vaccine safety have been ostracized, misquoted and even made to appear mentally ill by those who hold the majority opinion on the issue. Physicians who question vaccine safety have had their licenses threatened or have been fired from positions. Tactics such as name calling and the use of terms such as pseudo-science, (even when the evidence being presented is from widely accepted peer-reviewed journals) or “conspiracy theorists” which has the effect of placing those holding the minority opinion in the category of such groups as 9/11 truthers, are not uncommon. Other methods of curtailing the presentation of opposing vaccine views have included pressuring venues not to allow anti-vaccination proponents to appear, or using the media to “expose” anti-vaccination groups as “crack-pots” while simultaneously presenting the majority opinion and the presenters as the sole arbiters on the issue. The more extreme elements of the pro-vaccine group will even make the statement that the issue is settled and there is no need for discussion.

References

[1]  Rankin Jr, J.E. (2017) The Conspiracy Theory Meme as a Tool of Cultural Hegemony: A Critical Discourse Analysis. Doctoral Dissertation, Fielding Graduate University, Santa Barbara.
[2]  Jolley, D. and Douglas, K.M. (2014) The Effects of Anti-Vaccine Conspiracy Theories on Vaccination Intentions. PLoS ONE, 9, e89177.
[3]  Offit, P. (2017) Paul Offit: Trump Needs Vaccine Experts, Not Conspiracy Theorists.
http://www.thedailybeast.com/articles/2017/01/11/paul-offit-trump-needs-vaccine-experts-not-conspiracy-theorists.html
[4]  (2017)
http://vaccineconspiracytheorist.blogspot.com/
[5]  Reuben (2014) Being Anti-Vaccine Might Be Some Sort of Mental Disorder.
https://thepoxesblog.wordpress.com/2014/06/28/being-anti-vaccine-might-be-some-sort-of-mental-disorder/
[6]  Orac (2011) For the Anti-Vaccinationists Out There: The Results of a Real “Vaxed versus Unvaxed” Study. Science Blogs.
[7]  Simonis, A. and Smith, S. (2017)
http://www.heraldsun.com.au/news/inside-the-antivaccination-cult/news-story/10ba867d15778a30d88b3ae4ed262a05
[8]  Dave (2011) Anti-Vaccine Kooks Still at It. Skeptical Science.
http://www.skeptical-science.com/science/antivaccine-kooks/
[9]  (2017) A Shocking Truth Anti-Vaccine Nuts Don’t Want You to Know.
https://forwardprogressives.com/a-shocking-truth-anti-vaccine-nuts-dont-want-you-to-know/
[10]  Schewitz, M. (2014) How to Argue with the Anti-Vaccine Crazies: A Guide Popular Science.
http://www.popsci.com/science/article/2013-07/popsci-guide-anti-vaccine-claims
[11]  McDonald, C.R. (2017) Punch Anti-Vaxxers in the Face (with Facts).
https://progressivespring.com/2015/01/29/punch-anti-vaxxers-face-facts/
[12]  Poland, G.A. and Jacobson, R.M. (2011) The Age-Old Struggle against the Antivaccinationists. The New England Journal of Medicine, 364, 97-99.
https://doi.org/10.1056/NEJMp1010594
[13]  Dreger, A. (2017) What If Not All Parents Who Question Vaccines Are Foolish and Anti-Science?
http://www.newstatesman.com/2015/05/heretic-academy
[14]  The Vaccine Conspiracy Theorist.
http://vaccineconspiracytheorist.blogspot.com/
[15]  Martin, B. (2015) On the Suppression of Vaccination Dissent. Science and Engineering Ethics, 21, 143-157.
https://doi.org/10.1007/s11948-014-9530-3
[16]  Thinking Moms' Revolution (2015) Immunologist Tetyana Obukhanych: Unvaccinated Children Pose “No Extra Danger to the Public”.
http://thinkingmomsrevolution.com/an-open-letter-to-legislators-currently-considering-vaccine-legislation-from-tetyana-obukhanych-phd-in-immunology/
[17]  Tetyana the Undereducated (2017).
https://allaboutantivaxxers.wordpress.com/tag/tetyana-obukhanych/
[18]  The Original Skeptical Raptor (2017) Tetyana Obukhanych—Another Anti-Vaccine Appeal to False Authority.
https://www.skepticalraptor.com/skepticalraptorblog.php/appeal-to-false-authority-who-is-tetyana-obukhanych/
[19]  Inbar, R., et al. (2017) Behavioral Abnormalities in Young Female Mice Following Administration of Aluminum Adjuvants and the Human Papillomavirus (HPV) Vaccine Gardasil. Immunologic Research, 65, 136-149.
https://doi.org/10.1007/s12026-016-8826-6
[20]  (2017)
http://www.metronews.ca/news/vancouver/2016/02/16/ubc-prof-defends-study-linking-vaccine-and-behaviour-changes.html
[21]  Mawson, A.R., et al. (2017) Pilot Comparative Study on the Health of Vaccinated and Unvaccinated 6- to 12-Year-Old US Children. Journal of Translational Science, 3, 1-12.
[22]  Retraction Watch (2017) Updated: Vaccine-Autism Study Retracted—Again
http://retractionwatch.com/2017/05/08/retracted-vaccine-autism-study-republished/
[23]  News (2015) A Note from the Publisher.
https://www.thestar.com/news/2015/02/20/a-note-from-the-publisher.html
[24]  (2017)
http://www.nytimes.com/2012/07/15/us/fda-surveillance-of-scientists-spread-to-outside-critics.html?pagewanted=all
[25]  Martínez-Lavín, M. and Amezcua-Guerra, L. (2017) Serious Adverse Events after HPV Vaccination: A Critical Review of randomized Trials and Post-Marketing Case Series. Clinical Rheumatology, 1-10.
[26]  Mooney, C. (2017) The Science of Why We Don’t Believe Science.
http://www.motherjones.com/politics/2011/04/denial-science-chris-mooney/
[27]  Kirby, D. (2007) Evidence of Harm: Mercury in Vaccines and the Autism Epidemic: A Medical Controversy. St. Martin’s Press, New York.
[28]  Rising, K., Bacchetti, P. and Bero, L. (2008) Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation. PLoS Medicine, 5, e217.
https://doi.org/10.1371/journal.pmed.0050217
[29]  Pew Research Center (2015) Beyond Distrust: How Americans View Their Government.
http://www.people-press.org/2015/11/23/beyond-distrust-how-americans-view-their-government/
[30]  Policy and Medicine (2014) Public Distrust of Pharmaceutical Industry Could Harm Research and Development of Important Antibiotics.
http://www.policymed.com/2014/08/public-distrust-of-pharmaceutical-industry-could-harm-research-and-development-of-important-antibiotics.html
[31]  Keelan, J.E. (2006) Biopolitics and the Body Politic: Anti-Vaccinationism in Canada from a Historical Perspective. Comparative Program on Health and Society Lupina Foundation Working Papers Series 2004-2005, 78.
[32]  Wadman, M. (2017) Cleveland Clinic Will Discipline Doctor Who Wrote Antivaccination Column.
http://www.sciencemag.org/news/2017/01/cleveland-clinic-will-discipline-doctor-who-wrote-antivaccination-column
[33]  Stuart, E. (2015) Arizona Anti-Vaccine Doc to Keep His License Medical Board Rules.
http://www.phoenixnewtimes.com/news/arizona-anti-vaccine-doctor-to-keep-his-license-medical-board-rules-7511301
[34]  Tomljenovic, L., Pierre Spinosa, J. and A Shaw, C. (2013) Human Papillomavirus (HPV) Vaccines as an Option for Preventing Cervical Malignancies: (How) Effective and Safe? Current Pharmaceutical Design, 19, 1466-1487.
[35]  Rao, T.S. and Andrade, C. (2011) The MMR Vaccine and Autism: Sensation, Refutation, Retraction, and Fraud. Indian Journal of Psychiatry, 53, 95.
https://doi.org/10.4103/0019-5545.82529
[36]  Sharpe, M.A., Gist, T.L. and Baskin, D.S. (2013) B-Lymphocytes from a Population of Children with Autism Spectrum Disorder and Their Unaffected Siblings Exhibit Hypersensitivity to Thimerosal. Journal of Toxicology, 2013, Article ID: 801517.
https://doi.org/10.1155/2013/801517
[37]  Singh, V.K., Lin, S.X., Newell, E. and Nelson, C. (2002) Abnormal Measles-Mumps-Rubella Antibodies and CNS Autoimmunity in Children with Autism. Journal of Biomedical Science, 9, 359-364.
https://doi.org/10.1007/BF02256592
[38]  James, S.J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D.W. and Neubrander, J.A. (2004) Metabolic Biomarkers of Increased Oxidative Stress and Impaired Methylation Capacity in Children with Autism. The American Journal of Clinical Nutrition, 80, 1611-1617.
[39]  Holmes, A.S., Blaxill, M.F. and Haley, B.E. (2003) Reduced Levels of Mercury in First Baby Haircuts of Autistic Children. International Journal of Toxicology, 22, 277-285.
https://doi.org/10.1080/10915810305120
[40]  Tomljenovic, L. (2017) Regarding H.527.
http://www.vaxchoicevt.com/wp-content/uploads/2012/04/Lucija-Tomljenovic-PhD-letter.pdf
[41]  (2008) A Case of Junk Science, Conflict and Hype. Nature Immunology, 9, 1317.
http://www.nature.com/ni/journal/v9/n12/full/ni1208-1317.html?foxtrotcallback=true
https://doi.org/10.1038/ni1208-1317
[42]  Culp, D.R. and Berry, I. (2007) Merck and the Vioxx Debacle: Deadly Loyalty. Journal of Civil Rights and Economic Development, 22, 1-34.
[43]  Kaitin, K.I. (2007) Deconstructing the Drug Development Process: The New Face of Innovation. Clinical Pharmacology and Therapeutics, 87, 356-361.
https://doi.org/10.1038/clpt.2009.293
[44]  Krumholz, H.M., Ross, J.S., Presler, A.H. and Egilman, D.S. (2007) What Have We Learnt from Vioxx? British Medical Journal, 334, 120.
[45]  Smith, R. (2006) Lapses at the New England Journal of Medicine. Journal of the Royal Society of Medicine, 99, 380-382.
https://doi.org/10.1258/jrsm.99.8.380
[46]  Topol, E.J. (2004) Failing the Public Health—Rofecoxib, Merck, and the FDA. The New England Journal of Medicine, 351, 1707-1709.
https://doi.org/10.1056/NEJMp048286
[47]  McGoey, L. (2009) Pharmaceutical Controversies and the Performative Value of Uncertainty. Science as Culture, 18, 151-164.
https://doi.org/10.1080/09505430902885474
[48]  Ross, J.S., Hill, K.P., Egilman, D.S. and Krumholz, H.M. (2008) Guest Authorship and Ghostwriting in Publications Related to Rofecoxib: A Case Study of Industry Documents from Rofecoxib Litigation. JAMA, 299, 1800-1812.
https://doi.org/10.1001/jama.299.15.1800
[49]  Nesi, T. (2008) Poison Pills: The Untold Story of the Vioxx Drug Scandal. Thomas Dunne Books, New York.
[50]  Avorn, J. (2008) Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs. Vintage, 307-308.
[51]  Jureidini, J. and Clothier, R. (2009) Elsevier Should Divest Itself of Either Its Medical Publishing or Pharmaceutical Services Division. Lancet, 374, 375-376.
https://doi.org/10.1016/S0140-6736(09)61404-5
[52]  Chandler, R.E., Juhlin, K., Fransson, J., Caster, O., Edwards, I.R. and Norén, G.N. (2017) Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®. Drug Safety, 40, 81-90.
https://doi.org/10.1007/s40264-016-0456-3
[53]  álvarez-Soria, M.J., Hernández-González, A., Carrasco-García de León, S., del Real-Francia, M.A., Gallardo-Alcaniz, M.J. and López-Gómez, J.L. (2011) Demyelinating Disease and Vaccination of the Human Papillomavirus. Revue Neurologique, 52, 472-476.
[54]  Afdhal, N., McHutchison, J., Brown, R., et al. (2008) Thrombocytopenia Associated with Chronic Liver Disease. Journal of Hepatology, 48, 1000-1007.
https://doi.org/10.1016/j.jhep.2008.03.009
[55]  Orbach, H., Agmon-Levin, N. and Zandman-Goddard, G. (2010) Vaccines and Autoimmune Diseases of the Adult. Discovery Medicine, 9, 90-97.
[56]  Arnheim-Dahlstrom, L., Pasternak, B., Svanstrom, H., et al. (2013) Autoimmune, Neurological, and Venous Thromboembolic Adverse Events after Immunisation of Adolescent Girls with Quadrivalent Human Papillomavirus Vaccine in Denmark and Sweden: Cohort Study. BMJ, 347, f5906.
https://doi.org/10.1136/bmj.f5906
[57]  Gatto, M., Agmon-Levin, N., Soriano, A., et al. (2013) Human Papillomavirus Vaccine and Systemic Lupus Erythematosus. Clinical Rheumatology, 32, 1301-1307.
https://doi.org/10.1007/s10067-013-2266-7
[58]  Melo Gomes, S., et al. (2013) Vasculitis Following HPV Immunization. Rheumatology (Oxford), 52, 581-582.
https://doi.org/10.1093/rheumatology/kes168
[59]  American College of Pediatricians (2016) New Concerns about the Human Papillomavirus Vaccine.
http://www.acpeds.org/the-college-speaks/position-statements/health-issues/new-concerns-about-the-human-papillomavirus-vaccine
[60]  Sagonowsky, E. (2016) GSK Exits U.S. Market with Its HPV Vaccine Cervarix.
http://www.fiercepharma.com/pharma/gsk-exits-u-s-market-its-hpv-vaccine-cervarix
[61]  Palefsky, J.M. (2010) Human Papillomavirus-Related Disease in Men: Not Just a Women’s Issue. Journal of Adolescent Health, 46, 12-19.
https://doi.org/10.1093/rheumatology/kes168
[62]  Centers for Disease Control and Prevention (CDC) (2010) FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR, 59, 626-629.
[63]  Schwartz, J.L., Caplan, A.L., Faden, R.R. and Sugarman, J. (2007) Lessons from the Failure of Human Papillomavirus Vaccine State Requirements. Clinical Pharmacology & Therapeutics, 82, 760-763.
https://doi.org/10.1038/sj.clpt.6100397
[64]  Conrad, P. (2008) The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders. JHU Press, Baltimore, Maryland.
[65]  Rothman, B.K. (2000) Recreating Motherhood. Rutgers University Press, New Brunswick, New Jersey.
[66]  Bell, S.E. (1990) Sociological Perspectives on the Medicalization of Menopause. Annals of the New York Academy of Sciences, 592, 173-178.
https://doi.org/10.1111/j.1749-6632.1990.tb30325.x
[67]  Thomas-MacLean, R. and Stoppard, J.M. (2004) Physicians’ Constructions of Depression: Inside/Outside the Boundaries of Medicalization. Health, 8, 275-293.
https://doi.org/10.1177/1363459304043461
[68]  Lupton, D. (1997) Foucault and the Medicalisation Critique. In: Turner, B.S., Petersen, A.R. and Bunton, R., Eds., Foucault, Health and Medicine, Routledge, London, 94-110.
[69]  Moynihan, R., Heath, I. and Henry, D. (2002) Selling Sickness: The Pharmaceutical Industry and Disease Mongering. British Medical Journal, 324, 886.
https://doi.org/10.1136/bmj.324.7342.886
[70]  Lakoff, A. (2006) Pharmaceutical Reason: Knowledge and Value in Global Psychiatry. Cambridge University Press, Cambridge.
[71]  Williams, S.J., Gabe, J. and Davis, P. (2008) The Sociology of Pharmaceuticals: Progress and Prospects. Sociology of Health & Illness, 30, 813-824.
https://doi.org/10.1111/j.1467-9566.2008.01123.x
[72]  Greene, J.A. (2006) Prescribing by Numbers: Drugs and the Definition of Disease. The Johns Hopkins University Press, Baltimore, Maryland.
[73]  Rose, N. (2006) The Politics of Life Itself: Biomedicine, Power and Subjectivity in the Twenty-First Century. Princeton University Press, Princeton.
[74]  Healy, D. (2012) Pharmageddon. University of California Press, Berkeley.
[75]  Buttweiler, B.L. (2009) Because We Have the Power to Choose: A Critical Analysis of the Rhetorical Strategies Used in Merck’s Gardasil Campaign.
http://scholarworks.umt.edu/cgi/viewcontent.cgi?article=1108&context=etd
[76]  Aronowitz, R. (2010) Gardasil: A Vaccine against Cancer and a Drug to Reduce Risk. In: Wailoo, K., Livingston, J., Epstein, S. and Aronowitz, R., Eds., Three Shots at Prevention: The HPV Vaccine and the Politics of Medicine’s Simple Solutions, The Johns Hopkins University Press, Baltimore, 21-38.
[77]  Food and Drug Administration (FDA) (2013) What Is a Serious Adverse Event?
https://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm
[78]  Little, D.T. and Ward, H.R.G. (2012) Premature Ovarian Failure 3 Years after Menarche in a 16-Year-Old Girl Following Human Papillomavirus Vaccination. BMJ Case Reports.
[79]  Gatto, M., Agmon-Levin, N., Soriano, A., Manna, R., Maoz-Segal, R., Kivity, S. and Shoenfeld, Y. (2013) Human Papillomavirus Vaccine and Systemic Lupus Erythematosus. Clinical Rheumatology, 32, 1301-1307.
https://doi.org/10.1007/s10067-013-2266-7
[80]  Perez-Carmona, L., et al. (2010) The Quadrivalent Human Papillomavirus Vaccine: Erythema Multiforme and Cutaneous Side Effects after Administration. Dermatology, 221, 197-200.
https://doi.org/10.1159/000319852
[81]  Tomljenovic, L. and Shaw, C.A. (2012) Death after Quadrivalent Human Papillomavirus (HPV) Vaccination: Causal or Coincidental. Pharmaceutical Regulatory Affairs Journals, 12, 2.
[82]  Tomljenovic, L. and A Shaw, C. (2011) Aluminum Vaccine Adjuvants: Are They Safe? Current Medicinal Chemistry, 18, 2630-2637.
https://doi.org/10.2174/092986711795933740
[83]  Baylor, N.W., Egan, W. and Richman, P. (2002) Aluminum Salts in Vaccines—US Perspective. Vaccine, 20, S18-S23.
https://doi.org/10.1016/S0264-410X(02)00166-4
[84]  Lerner, A. (2012) Aluminum as an Adjuvant in Crohn’s Disease Induction. Lupus, 21, 231-238.
https://doi.org/10.1177/0961203311430090
[85]  Exley, C. (1999) A Molecular Mechanism of Aluminum-Induced Alzheimer’s Disease? Journal of Inorganic Biochemistry, 76, 133-140.
https://doi.org/10.1016/S0162-0134(99)00125-7
[86]  Shaw, C.A. and Petrik, M.S. (2009) Aluminum Hydroxide Injections Lead to Motor Deficits and Motor Neuron Degeneration. Journal of Inorganic Biochemistry, 103, 1555-1562.
https://doi.org/10.1016/j.jinorgbio.2009.05.019
[87]  Merck & Co, Inc. (2009) Gardasil Package Insert. Merck & Co, Inc., Kenilworth, New Jersey,
[88]  Slade, B.A., Leidel, L., Vellozzi, C., Woo, E.J., Hua, W., Sutherland, A. and Markowitz, L.E. (2009) Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine. JAMA, 302, 750-757.
https://doi.org/10.1001/jama.2009.1201
[89]  Debold, V. and Hurwitz, E. (2009) Adverse Events and Quadrivalent Human Papillomavirus Recombinant Vaccine. JAMA, 302, 2657-2658.
https://doi.org/10.1001/jama.2009.1880
[90]  Tomljenovic, L. and Shaw, C.A. (2013) Human Papillomavirus (HPV) Vaccine Policy and Evidence-Based Medicine: Are They at Odds? Annals of Medicine, 45, 182-193.
https://doi.org/10.3109/07853890.2011.645353
[91]  RI Dept of Health, Waging a War against Your Rights. State of Rhode Island Dept. of Health.
https://nohpvmandateri.wordpress.com/2017/04/08/ri-dept-of-health-waging-a-war-against-your-rights/
[92]  About VAERS—Centers for Disease Control (2017) Annual Reports to VAERS.
[93]  Rosenthal, S. and Chen, R. (1995) The Reporting Sensitivities of Two Passive Surveillance Systems for Vaccine Adverse Events. American Journal of Public Health, 85, 1706-1709.
https://doi.org/10.2105/AJPH.85.12.1706
[94]  Braun, M.M. (2017) Vaccine Adverse Event Reporting System (VAERS) Usefulness and Limitations.
http://www.vaccinesafety.edu/VAERS-Braun.htm
[95]  Harper, D.M. (2009) Currently Approved Prophylactic HPV Vaccines. Expert Review of Vaccines, 8, 1663-1679.
[96]  Yerman, M.G. (2009) An Interview with Dr. Diane M. Harper, HPV Expert. THE BLOG.
[97]  Hirth, J.M., Tan, A., Wilkinson, G.S. and Berenson, A.B. (2013) Compliance with Cervical Cancer Screening and Human Papillomavirus Testing Guidelines among Insured Young Women. American Journal of Obstetrics and Gynecology, 209, 200-e1.
https://doi.org/10.1016/j.ajog.2013.05.058
[98]  Judicial Watch (2017) The First Six Pages of the Judicial Watch Special Report Examining the FDA’s HPV Vaccine Records.
https://uncensored.co.nz/2009/03/27/a-judicial-watch-special-report-examining-the-fda%E2%80%99s-hpv-vaccine-records/
[99]  Guo, F., Hirth, J.M. and Berenson, A.B. (2015) Comparison of HPV Prevalence between HPV-Vaccinated and Non-Vaccinated Young Adult Women (20 - 26 Years). Human Vaccines & Immunotherapeutics, 11, 2337-2344.
https://doi.org/10.1080/21645515.2015.1066948
[100]  Gerhardus, A. and Razum, O. (2010) A Long Story Made Too Short: Surrogate Variables and the Communication of HPV Vaccine Trial Results. Journal of Epidemiology and Community Health, 64, 377-378.
https://doi.org/10.1136/jech.2009.090183
[101]  Spinosa, J.P. (2011) Letter to the Editor Response to the Article of Luisa Lina Villa HPV Prophylactic Vaccination: The First Years and What to Expect from Now. Cancer Letters, 304, 70.
https://doi.org/10.1016/j.canlet.2011.01.024
[102]  Food and Drug Administration (FDA) (2006) VRBPAC Background Document: Gardasil HPV Quadrivalent Vaccine.
https://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4222B3.pdf
[103]  Herrero, R., Quint, W., Hildesheim, A., Gonzalez, P., Struijk, L. and Katki, H.A. (2013) Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica. PLoS ONE, 8, e68329.
https://doi.org/10.1371/journal.pone.0068329
[104]  Harper, D.M. and Williams, K.B. (2010) Prophylactic HPV Vaccines: Current Knowledge of Impact on Gynecologic Premalignancies. Discovery Medicine, 10, 7-17.
[105]  CBS News (2009) Gardasil Researcher Speaks Out.
https://www.cbsnews.com/news/gardasil-researcher-speaks-out/
[106]  Jefferson, T. and Jorgensen, L. (2016) Human Papillomavirus Vaccines, Complex Regional Pain Syndrome, Postural Orthostatic Tachycardia Syndrome, and Autonomic Dysfunction—A Review of the Regulatory Evidence from the European Medicines Agency. Indian J Med Ethics, 2.
[107]  Clendinen, C., Zhang, Y., Warburton, R.N. and Light, D.W. (2016) Manufacturing Costs of HPV Vaccines for Developing Countries. Vaccine, 34, 5984-5989.
https://doi.org/10.1016/j.vaccine.2016.09.042
[108]  Silverman (2013) Merck & Its HPV Vaccine: Sales & Skepticism Are Both Up.
https://www.forbes.com/sites/edsilverman/2013/03/27/merck-its-hpv-vaccine-sales-skepticism-are-both-up/#6ae036ff49dc
[109]  Mello, M.M., Abiola, S. and Colgrove, J. (2012) Pharmaceutical Companies’ Role in State Vaccination Policymaking: The Case of Human Papillomavirus Vaccination. American Journal of Public Health, 102, 893-898.
https://doi.org/10.2105/AJPH.2011.300576
[110]  (2017)
https://www.wsj.com/articles/new-approach-to-promoting-hpv-vaccinations-1476727458
[111]  Velan, B. and Yadgar, Y. (2017) On the Implications of Desexualizing Vaccines against Sexually Transmitted Diseases: Health Policy Challenges in a Multicultural Society. Israel Journal of Health Policy Research, 6, 30.
https://doi.org/10.1186/s13584-017-0153-4
[112]  Pegler, S. and Underhill, J. (2010) Evaluating the Safety and Effectiveness of New Drugs. American Family Physician, 82, 53-57.
https://doi.org/10.1097/AOG.0b013e3181fe61f4
[113]  Schiffman, M., Castle, P.E., Jeronimo, J., Rodriguez, A.C. and Wacholder, S. (2007) Human Papillomavirus and Cervical Cancer. The Lancet, 370, 890-907.
https://doi.org/10.1016/S0140-6736(07)61416-0
[114]  Harper, D.M., Vierthaler, S.L. and Santee, J.A. (2010) Review of Gardasil. Journal of Vaccines & Vaccination, 1, 107.
https://doi.org/10.4172/2157-7560.1000107

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133